What is the official ID of this bill?
The official print number for this legislation is HR 1587.
Affordable Insulin for Youth: Lower Diabetes Treatment Costs
New rules aim to reduce insulin costs for individuals aged 26 and younger with private health plans or Medicaid. Starting January 1, 2024, insurers cannot apply deductibles or charge more than $35 or 25% of the negotiated price for a 30-day supply of insulin. This is intended to significantly ease the financial burden on young diabetes patients and their families.
Key points
Insulin cost cap: Individuals 26 and younger will pay no more than $35 or 25% of the negotiated price for a 30-day supply of insulin.
No deductibles: Insurers cannot apply deductibles for selected insulin products for this age group.
Applies to private plans and Medicaid: The changes cover both private health insurance and the Medicaid program.
Effective from 2024: New rules come into effect on January 1, 2024.
Costs count towards limits: Any insulin cost-sharing payments will count towards annual out-of-pocket maximums.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.